Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Pediatric Surgery Case Reports|July 24, 2020
Pleuropulmonary blastoma in an adolescentLaura V Bownes, Sara C Hutchins, Agustin M Cardenas, et al.Journal of Pediatric Surgery|April 3, 2024
PIM Kinase Inhibition Sensitizes Neuroblastoma to DoxorubicinJanet R Julson, Colin H Quinn, Nazia Nazam, et al.Journal of Pediatric Surgery|March 12, 2023
Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal PhenotypeJanet R Julson, Colin H Quinn, Laura V Bownes, et al.Journal of Pediatric Surgery|March 14, 2020
Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastomaRaoud Marayati, Adele P Williams, Laura V Bownes, et al.Journal of Pediatric Surgery|March 25, 2021
PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastomaNikita Wadhwani, Hooper R Markert, Raoud Marayati, et al.Journal of Pediatric Surgery|November 2, 2023
CDK4/6 Inhibition With Lerociclib is a Potential Therapeutic Strategy for the Treatment of Pediatric SarcomasJanet R Julson, Sara C Horton, Colin H Quinn, et al.Journal of Pediatric Surgery|March 11, 2022
Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK)Laura V Bownes, Raoud Marayati, Colin H Quinn, et al.Translational Oncology|October 3, 2020
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Laura L Stafman, et al.Journal of Pediatric Surgery|March 25, 2021
Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Colin H Quinn, et al.ACS Omega|September 19, 2022
Rapid Characterization of Solid Tumors Using Resonant SensorsAndee M Beierle, Colin H Quinn, Hooper R Markert, et al.Pageof 3